SUMMARY

Personalized medicine is a major research goal for this century. There are however multiple challenges and hurdles to achieve personalized risks prediction, prevention and therapeutic interventions for common complex benign and malignant diseases. Latest technological advances in DNA sequencing allow promise for identification of genetic and genomic variation – single-nucleotide-polymorphisms (SNPs) and copy number variation (CNV) that might govern diagnosis, prevention and treatment of human disorders.